ArticleJournal of clinical immunology2024

Rapamycin Controls Lymphoproliferation and Reverses T-Cell Responses in a Patient with a Novel STIM1 Loss-of-Function Deletion.

Ibrahim Serhat Karakus et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.